Medical Services Gets Significant Interest in Its Dual VScan Test Kit
November 15 2007 - 1:36PM
PR Newswire (US)
EDMONTON, Alberta, Nov. 15 /PRNewswire-FirstCall/ -- Medical
Services International Inc. (Pink Sheets: MSITF) is pleased to
announce that as a result of the excellent independent test results
obtained by regulatory agencies related to the VScan HIV and TB
test kits, interest in the dual VScan test kit that detects HIV and
TB simultaneously has increased substantially. HIV and TB are known
to be closely associated. It is very difficult to get individuals
to make themselves available for the 3 to 4 days that it takes to
test for both diseases. With the VScan dual test kit, the testing
for both diseases can be done in 30 minutes. Forty (40%) of the
individuals with HIV have active TB. TB is very contagious but
treatable if diagnosed correctly. Use of this test dual test kit
will help to reduce the spread of TB within the community while
helping to detect HIV. Medical Services is the only company that
has developed a test for detecting both TB and HIV at the same
time. Countries currently using the VScan test kits for HIV and TB
are particularly interested in the dual kit. Preliminary
indications are that the market will be very large for the dual
test kits. Medical Services International Inc. trades in the United
States on the NQB Pink Sheets under the symbol "MSITF". For further
information, please contact Robert Talbot at (780) 430 6363 or
http://www.medicalservicesintl.com/ or
http://www.minerva-biotech.com/. Note: Certain statements in this
press release are "forward-looking statements" within the meaning
of the Private Securities Act of 1995. Such statements involve
known and unknown risks, uncertainties and other factors that may
cause results to differ materially. Such risks, uncertainties and
other factors include but are limited to new economic conditions,
risk in product development, market acceptance of new products and
continuing product demand, level of competition and other factors
described in Company reports and filings with regulatory bodies.
DATASOURCE: Medical Services International Inc. CONTACT: Robert
Talbot of Medical Services International Inc., +1-780-430-6363 Web
site: http://www.medicalservicesintl.com/
http://www.minerva-biotech.com/
Copyright